Health-care companies were flat as momentum in the sector stalled.
Obesity drug maker Novo Nordisk and Eli Lilly gave back some of their recent gains. Omeros shares tumbled after the clinical-stage biopharmaceutical company posted a wider quarterly loss.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
05-16-24 1750ET
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 927.3 DKK | +1.13% | -0.16% | 598B | ||
| 820.3 USD | +0.65% | +1.60% | 739B | ||
| 3.36 USD | +1.20% | +0.30% | 195M | ||
